DNLI Operating Cash Flow (Statement)
Denali Therapeutics Inc · Operating Cash Flow (Statement)
DNLI Operating Cash Flow (Statement)
Latest reported-$97.00Mperiod ending
DNLI Quarterly Cash from Operations (-$16.35M → -$97.00M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
DNLI operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -97,002,000 | |
| -131,204,000 | |
| -98,538,000 | |
| -107,296,000 | |
| -75,298,000 | |
| -131,468,000 | |
| -83,715,000 | |
| -59,139,000 | |
| -91,220,000 | |
| -113,620,000 | |
| -98,657,000 | |
| -87,363,000 | |
| -113,169,000 | |
| -58,802,000 | |
| -72,663,000 | |
| -57,046,000 | |
| -42,898,000 | |
| -72,109,000 | |
| -65,494,000 | |
| -41,434,000 | |
| -54,221,000 | |
| -50,240,000 | |
| 513,914,999 | |
| 86,000 | |
| -43,357,000 | |
| -54,492,000 | |
| -47,643,000 | |
| -30,435,000 | |
| -43,175,000 | |
| -30,323,000 | |
| 93,185,000 | |
| -34,822,000 | |
| -41,824,000 | |
| 33,577,000 | |
| -18,336,000 | |
| -21,921,000 | |
| -17,569,000 | |
| -18,809,000 | |
| -18,366,000 | |
| -21,287,000 | |
| -16,353,000 | |
| -16,353,000 |